 SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Feb. 07, 2022 GLOBE NEWSWIRE -- Zai Lab Limited NASDAQ: ZLAB; HKEX: 9688, a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following virtual investor conference in February: 